These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4817707)

  • 21. Ethyl-3-ethoxycarbonyl-4-hydroxy-2H-1,2-benzothiazine-2-acetate-1,1-dioxide, a compound producing ventricular arrhythmias.
    Pruss TP
    Toxicol Appl Pharmacol; 1969 Jan; 14(1):1-5. PubMed ID: 4180304
    [No Abstract]   [Full Text] [Related]  

  • 22. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias.
    Nygaard TW; Sellers TD; Cook TS; DiMarco JP
    JAMA; 1986 Jul; 256(1):55-7. PubMed ID: 3712714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Wyse DG; Mitchell LB; Duff HJ
    J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of recurrent symptomatic ventricular tachycardia.
    Winkle RA; Alderman EL; Fitzgerald JW; Harrison DC
    Ann Intern Med; 1976 Jul; 85(1):1-7. PubMed ID: 937905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cardiac arrhythmias in dogs with gastric distention-volvulus.
    Muir WW; Bonagura JD
    J Am Vet Med Assoc; 1984 Jun; 184(11):1366-71. PubMed ID: 6735858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ventricular tachycardia and "volley of ventricular spikes". Morphological frontiers between ventricular dysrhythmias].
    Slama R; Coumel P; Motte G; Gourgon R; Waynberger M; Touche S
    Arch Mal Coeur Vaiss; 1973 Nov; 66(11):1401-11. PubMed ID: 4132889
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects.
    Lown B; Temte JV; Arter WJ
    Circulation; 1973 Jun; 47(6):1364-81. PubMed ID: 4709549
    [No Abstract]   [Full Text] [Related]  

  • 30. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.
    Sami M; Harrison DC; Kraemer H; Houston N; Shimasaki C; DeBusk RF
    Am J Cardiol; 1981 Jul; 48(1):147-56. PubMed ID: 6787910
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of phenytoin in the management of ventricular arrhythmias induced by hypokalaemia.
    O'Reilly MV; MacDonald RT
    Br Heart J; 1973 Jun; 35(6):631-4. PubMed ID: 4712468
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-arrhythmia therapy with special reference to quinidine].
    Just H
    Cardiology; 1983; 70 Suppl 1():97-107. PubMed ID: 6189611
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac arrhythmias. Rationale of drug therapy.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of supraventricular tachyarrhythmias.
    Orlando J; Aronow WS
    Arch Intern Med; 1979 Nov; 139(11):1298-301. PubMed ID: 508027
    [No Abstract]   [Full Text] [Related]  

  • 36. [II. Drug therapy of heart rhythm disorders].
    Heinrich F; Schultis K
    Med Welt; 1967 Feb; 6():333-6. PubMed ID: 4174287
    [No Abstract]   [Full Text] [Related]  

  • 37. The assessment of an antiarrhythmic agent, sustained-release procainamide, with the aid of Holter monitoring.
    Bauer GE; Mitchell AS; Bates F; Hellestrand K
    Med J Aust; 1977 Nov; 2(22):733-5. PubMed ID: 347229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
    Cosnier D; Grimal J; Duchene-Marullaz P
    Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.